Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone in Moderate to Severe CHF
NCT00696631Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jun 2002
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Dronedarone with Placebo (2 arms). Primary endpoint: Death from any cause or adjudicated hospitalization for worsening heart failure. Started Jun 2002; status: terminated.
02
Drugs
dronedarone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00696631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696631.